Human Pathology
Volume 40, Issue 7 , Pages 957-964 , July 2009

p16, Ki-67, and BD ProEx™C immunostaining: a practical approach for diagnosis of cervical intraepithelial neoplasia

Received 19 September 2008 ,Revised 11 December 2008 ,Accepted 11 December 2008.

References 

  1. Hu L, Guo M, He Z, Thornton J, McDaniel LS, Hughson MD. Human papillomavirus genotyping and p16INK4a expression in cervical intraepithelial neoplasia of adolescents. Mod Pathol. 2005;18:267–273
  2. Kelly D, Kincaid E, Fansler Z, Rosenthal DL, Clark DP. Detection of cervical high-grade squamous intraepithelial lesions from cytologic samples using a novel immunocytochemical assay (ProEx C). Cancer. 2006;108:494–500
  3. Klaes R, Benner A, Friedrich T, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol. 2002;26:1389–1399
  4. O'Neill CJ, McCluggage WG. P16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol. 2006;13:8–15
  5. Sano T, Masuda N, Oyama T, Nakajima T. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol Int. 2002;52:375–383
  6. Ortega S, Malumbres M, Barbacid M. Cyclin D–dependent kinases INK4 inhibitors and cancer. Biochim Biophys Acta. 2002;1602:73–87
  7. Indinnemo M, Cicchini C, Stazi A, et al. Immunohistochemical assessment of Ki-67 as prognostic cellular proliferation marker in anal canal carcinoma. J Exp Clin Cancer Res. 2000;19:471–475
  8. Chen Y, Miller C, Mosher R, et al. Identification of cervical cancer markers by cDNA and tissue microarrays. Cancer Res. 2003;63:1927–1935
  9. Malinowski DP. Multiple biomarkers in molecular oncology. I. Molecular diagnostics applications in cervical cancer detection. Expert Rev Mol Diagn. 2007;7:117–131
  10. Santin AD, Zhan F, Bignotti E, et al. Gene expression profiles of primary HPV 16– and HPV 18–infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virology. 2005;331:269–291
  11. Badr RE, Walts AE, Chung F, Bose S. BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix. Am J Surg Pathol. 2008;32:899–906
  12. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001;92:276–284
  13. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol. 1998;153:1741–1748
  14. Pinto AP, Schlecht NF, Woo TYC, Crum CP, Cibas ES. Biomarker (ProEx™C, p16(INK4A), and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics. Mod Pathol. 2008;21:1067–1074
  15. Redman R, Rufforny I, Liu C, Wilkinson EJ, Massoll NA. The utility of p16(Ink4a) in discriminating between cervical intraepithelial neoplasia 1 and nonneoplastic equivocal lesions of the cervix. Arch Pathol Lab Med. 2008;132:795–799
  16. Shi J, Liu H, Wilkerson M, et al. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions. Hum Pathol. 2007;38:1335–1344
  17. Walts AE, Bose S. P16/Ki-67 immunostaining is useful in stratification of atypical metaplastic epithelium of the cervix. Clinical Medicine: Pathology. 2008;1:35–42[Electronic publication]
  18. Iaconis L, Hyjek E, Ellenson LH, Pirog EC. p16 and Ki-67 immunostaining in atypical immature squamous metaplasia of the uterine cervix: correlation with human papillomavirus detection. Arch Pathol Med. 2007;131:1343–1349
  19. Wong AK, Chan RCK, Nichols WS, et al. Human papillomavirus (HPV) in atypical squamous cervical cytology: the Invader HPV Test as a new screening assay. J Clin Microbiol. 2008;46:869–875
  20. Walts AE, Lechago J, Bose S. P16 and Ki-67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia. Am J Surg Pathol. 2006;30:795–801
  21. Agoff SN, Lin P, Morihara J, Mao C, Kiviat NB, Koutsky LA. p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol. 2003;16:665–673
  22. Van Niekerk D, Guillaud M, Matisic J, et al. p16 and MIB1 improve the sensitivity and specificity of the diagnosis of high grade squamous intraepithelial lesions: methodological issues in a report of 447 biopsies with consensus diagnosis and HPV HCII testing. Gynecol Oncol. 2007;107(1 Suppl 1):S233–S240[Electronic publication 2007 Sep 7]
  23. Qiao X, Bhuiya TA, Spitzer M. Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E, and p16 immunohistochemical analysis. J Low Genit Tract Dis. 2005;9:100–107

 This study was presented in part at the USCAP annual meeting, Denver, CO, March 2008.

PII: S0046-8177(08)00577-7

doi: 10.1016/j.humpath.2008.12.005

Human Pathology
Volume 40, Issue 7 , Pages 957-964 , July 2009